Weighted-Average Shares

9 Months Ended

Oct. 01, 2023

Weighted-average shares were calculated as follows (in thousands):


	Three-months Ended		Nine-months Ended
	October 1, 2023	October 2, 2022	October 1, 2023	October 2, 2022
Basic weighted-average common shares outstanding	172,169	173,256	172,408	173,640
Effect of dilutive equity awards	1,185	1,071	1,251	1,593
Weighted-average common and common-equivalent shares outstanding	173,354	174,327	173,659	175,233

Stock options to purchase 6,893,000 and 6,775,000 shares of common stock, on a weighted-average basis, were outstanding during the three-month and nine-month periods ended October 1, 2023, respectively, and 6,167,000 and 3,297,000 for the same periods in 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 3,000 and 1,000 shares of common stock, on a weighted-average basis, were outstanding during the three-month and nine-month periods ended October 1, 2023, respectively, and 607,000 and 26,000 for the same periods in 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No PRSUs were excluded in the calculation of dilutive net income per share for the three-month and nine-month periods ended October 1, 2023, as PRSUs were not anti-dilutive on a weighted-average basis. PRSUs totaling 33,000 shares of common stock, on a weighted average basis, were outstanding during the three-month period ended October 2,

2022, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No PRSUs were excluded in the calculation of dilutive net income per share for the nine-month period ended October 2, 2022 as PRSUs were not anti-dilutive on a weighted-average basis.